Opportunity for the HORIZON-HLTH-2022-DISEASE-06-04-two-stage funding call

Development of new effective therapies for rare diseases

Stage 1 Deadline:

February 01, 2022

Stage 2 Deadline:

September 06, 2022

Project types:

  1. HORIZON-RIA HORIZON Research and Innovation Actions

Project Proposal

The call HORIZON-HLTH-2022-DISEASE-06-04-two-stage has been scheduled to close, so this opportunity is no longer current.

Alpha Bioresearch is a spanish CRO who has led clinical research projects for more than 25 years.

We have experience in Horizon 2020 funds (A-TANGO, CARBALIVE projects), where we can act as a partner of the consortium.

Also we have established partnerships with specialised consultants in providing support for the request for a technical proposal and financial control of the project.

We can be partners of any project in HORIZON-HLTH-2022-DISEASE or similar with clinical trials. We can cover all therapeutic areas.

If you need support in your clinical trials, please get in touch.